ImmunologybioRxivPreprint
Hybrid immunity elicits potent cross-variant ADCC against SARS-CoV-2 through a combination of anti-S1 and S2 antibodies
M. D. Grant, K. Bentley, C. A. Fielding…·K. A. Holder
This study shows that hybrid immunity, from prior infection followed by vaccination, generates stronger and broader antibody-dependent cellular cytotoxicity (ADCC) against SARS-CoV-2 variants than vaccination alone.
DOI 10.1101/2023.03.09.531709